Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.
Below are the newest and most recently updated Shortage and Discontinuation reports.
|Brand name||Company Name||Status||Strength||Update||Date Updated||View Report|
|ALIMTA||ELI LILLY CANADA INC||Discontinued||500MG||Updated Report||2021-09-18||136207|
|GLYXAMBI||BOEHRINGER INGELHEIM (CANADA) LTD LTEE||To be discontinued||5MG 25MG||Updated Report||2021-09-17||139877|
|VALSARTAN||SIVEM PHARMACEUTICALS ULC||Discontinued||40MG||New Report||2021-09-09||145415|
|ATROPINE SULFATE INJECTION USP||PFIZER CANADA ULC||Discontinued||0.5MG||Updated Report||2021-09-08||145250|
|DOXORUBICIN||PFIZER CANADA ULC||Discontinued||2MG||Updated Report||2021-09-07||145256|